Chronic myeloid leukaemia trials in Netherlands

In Netherlands 9 Also abroad 171

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Where
Utrecht
Age
1 year to 18 years
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07354074
Phase 1/2Taking people
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Where
Utrecht
Age
1 year to 17 years
People
70 worldwide
Run by
Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00
Phase 2Taking people
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Where
Groningen
Age
18 years and over
People
140 worldwide
Run by
Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00
Phase 2Taking people
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Where
Utrecht
Age
Up to 17 years
People
16 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00
Phase 1/2Not yet taking people in Netherlands
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
Where
Amsterdam, Groningen, Maastricht, Nijmegen
Age
18 years and over
People
64 worldwide
Run by
Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00
Phase 1/2Taking people
Study to Evaluate the Safety and Tolerability of EP0042
Where
Amsterdam, Rotterdam
Age
18 years and over
People
70 worldwide
Run by
Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00
Phase 1Taking people
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Where
Nijmegen
Age
18 years and over
People
250 worldwide
Run by
Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00
Phase 2Taking people
A multicenter trial where patients with CML stop medication a second time.
Where
Amsterdam
Age
18 years and over
People
32 worldwide
Run by
Region Uppsala
See details and how to join2024-515409-25-00 · EU 2024-515409-25-00
No phaseTaking people
International Chronic Myeloid Leukemia Pediatric Study
Where
Utrecht
Age
Up to 18 years
People
750 worldwide
Run by
Poitiers University Hospital
See details and how to joinNCT01281735